Medical Research News

RSS

Hurricanes pose long-term health risks for vulnerable older adults

New research in the Journal of the American Geriatrics Society indicates that older adults who rely on electricity-dependent medical devices-such as ventilators, respirators, and dialysis machines-may face substantial health risks during and after hurricanes, especially in communities experiencing severe flooding.

21 Oct 2026

Regular tea consumption linked to lower risk of vascular disease

In a Journal of Internal Medicine study, people who drank tea had a lower risk of vascular disease than non–tea drinkers.

21 Oct 2026

A nine-year study reveals a pattern linking loneliness to heart risk

The study reveals that patterns of loneliness and social isolation significantly impact heart health, suggesting new avenues for cardiovascular risk assessment.

21 Oct 2026

Oxaloacetate supplement may help reduce chemo brain in breast cancer survivors

A new study led by researchers at the UCLA Health Jonsson Comprehensive Cancer Center found that a nutritional supplement containing oxaloacetate, a molecule naturally found in the body that helps cells produce energy, may help improve cognitive function and reduce the fatigue experienced by some breast cancer survivors following treatment.

21 Oct 2026

Could a hormone from our bones reveal early signs of insulin resistance?

Research reveals a link between osteocalcin and insulin resistance in obese children, suggesting early metabolic changes before glucose tolerance impairment.

21 Oct 2026

Touchlight announces leadership transition, with Will Downie appointed interim CEO

Touchlight today announces that Karen Fallen is stepping down as CEO and that the Board of Directors has appointed Will Downie as Interim Chief Executive Officer.

From Touchlight 21 Oct 2026

Qureight appointed imaging CRO for Phase 3 SURPASS-IPF trial as partnership with Celea Therapeutics expands

Qureight, an end-to-end imaging CRO providing enterprise-grade imaging and precision endpoints for clinical trials for lung and heart disease, today announced it has been selected by Celea Therapeutics as the imaging CRO to support Celea’s Phase 3 SURPASS-IPF clinical trial.

From Qureight 21 Oct 2026

Why did people report feeling better during COVID-19? A French study offers clues

Assessing well-being in France (2014-2023), the study finds COVID-19 influenced scores, with health symptoms significantly affecting emotional health.

21 Oct 2026

Young adults increasingly use high-nicotine e-cigarettes, study finds

Researchers from University of California San Diego Herbert Wertheim School of Public Health and Human Longevity Science have found that high-nicotine e-cigarette use rose sharply among young adults between 2017 and 2022 and was associated with increased nicotine dependence and more persistent vaping.

21 Oct 2026

Diverse social activities may help slow age-related cognitive decline

Diverse and sustained social activities may boost cognitive performance and slow the decline in brain health associated with aging, suggest the findings of a large international study, published online in the Journal of Epidemiology & Community Health.

21 Oct 2026

Pure cranberry juice may help protect teeth from decay

Boil them, mash them, simmer them in a sauce. Whether they’re sweetening a salad, garnishing a cocktail or brightening up home décor, cranberries are an iconic ingredient in holiday festivities.

21 Oct 2026

ScionxBio announces collaboration to develop long-acting xRNA therapeutics

ScionxBio (the "company", operating as a brand identity of Eleven Therapeutics Ltd. following a horizontal split) a privately held, preclinical-stage biotechnology company pioneering next-generation mRNA therapeutics, distinguished by their extended durability profile, today announced that it has entered into a worldwide strategic collaboration and licensing agreement with Sanofi to develop and commercialize extended exposure versions of certain Sanofi mRNA candidates by leveraging ScionxBio's proprietary TERA® platform.

From ScionxBio 21 Oct 2026

Combination approach slows osteosarcoma growth and prolongs survival in preclinical models

Scientists co-led by St. Jude Children's Research Hospital have identified a potential therapeutic vulnerability in some forms of osteosarcoma.

20 Oct 2026

CT scans reveal body composition changes preceding pancreatic cancer diagnosis

People who develop pancreatic cancer experience measurable changes in body composition years before diagnosis that differ from those seen in similar individuals without cancer, according to a Mayo Clinic study led by former Mayo Clinic research fellow, Aleksander Bogdanski and published in Pancreatology.

20 Oct 2026

Alzheimer’s biomarkers may help predict disease progression in ALS

Amyotrophic lateral sclerosis (ALS) is a serious neurodegenerative disease in which the nerve cells that control the body's muscles break down.

20 Oct 2026

Paternal age may influence sex-specific gene expression changes in embryos

When genes are "expressed," it is like reading an instruction manual to create things the body needs - such as proteins or RNA.

20 Oct 2026

Researchers identify new depression subtype linked to the body clock

Research by experts at the University of Sydney has identified a new subtype of depression called "circadian depression".

20 Oct 2026

Study identifies potential treatment target for aggressive lung tumors

A UTHealth Houston-led team has identified a promising new avenue to curb the growth and spread of tumors associated with hard-to-treat lung and other cancers.

20 Oct 2026

$52 million study to investigate why some infants develop lasting lung infections

A Michigan Medicine-led research consortium has secured approval for up to $52 million in federal funding to launch a multicenter study examining why some young children recover fully from viral lower respiratory tract infections while others develop severe illness or lasting problems such as asthma.

20 Oct 2026

Daily vaping in the US rises by 230% from 2013-14

More people are likely vaping, and with greater frequency, in the US since 2013-14, suggests a data analysis published online in the journal Tobacco Control.

20 Oct 2026